Insider filing · NUVL

Matthew Shair sold $6.0M of Nuvalent (NUVL)

Executed Oct 27 2025, disclosed Oct 29 2025, 2 days later.

Returns are measured on stock purchases only.

MS Matthew Shair Director profile →

Matthew Shair (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Nuvalent Inc (NUVL). The largest single filing was $6.0M of NUVL (60,000 sh across 4 lots, as filed), executed Oct 27 2025.

NUVL Nuvalent Inc NUVL · Healthcare · 94 filings in 24 months ticker →

Healthcare · Nuvalent, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→